Phase II Study of Defactinib (VS6063) in Patients With Tumors With NF2 Loss: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol U is a research paper published in JCO Precision Oncology (2024). On theSindex it has a DataRank of 0.260. It has been cited 4 times, with 4 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
0.0184
From 2 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 4 citers.
NCI NIH HHS
Grant: UG1 CA233302
NCI NIH HHS
Grant: UG1 CA233180
NCI NIH HHS
Grant: UG1 CA233290
NCI NIH HHS
Grant: UG1 CA233341
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: U10 CA180888
NCI NIH HHS
Grant: U10 CA180794
NCI NIH HHS
Grant: U10 CA180820
NCI NIH HHS
Grant: UG1 CA233329
NCI NIH HHS
Grant: U10 CA180868
FWCI
1.33
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals